|
May 29
|
Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency
|
|
May 28
|
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
|
|
May 14
|
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences
|
|
May 14
|
Q1 2025 Eton Pharmaceuticals Inc Earnings Call
|
|
May 14
|
Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Call Highlights: Revenue Soars 117% Amid ...
|
|
May 13
|
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
|
|
May 13
|
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
|
|
Apr 15
|
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability
|
|
Mar 14
|
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
|
|
Feb 20
|
Intellia Therapeutics (NTLA) Stock Jumps 6.5%: Will It Continue to Soar?
|
|
Feb 10
|
Eton secures US patent for diabetes insipidus treatment
|
|
Jan 28
|
New Strong Buy Stocks for January 28th
|
|
Jan 25
|
Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum
|
|
Jan 24
|
Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?
|
|
Jan 3
|
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
|
|
Oct 3
|
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
|
|
Aug 2
|
Shareholders in Eton Pharmaceuticals (NASDAQ:ETON) are in the red if they invested five years ago
|
|
Jul 30
|
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
|
|
Jul 15
|
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
|
|
Jun 22
|
Are Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
|